|
17 Sep 2025 |
Colgate-Palmolive
|
Consensus Share Price Target
|
2347.80 |
2522.65 |
- |
7.45 |
hold
|
|
|
|
|
25 May 2016
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2347.80
|
940.00
|
839.70
(179.60%)
|
Target met |
Buy
|
|
|
ICICI Securities Ltd | Retail Equity Research Colgate-Palmolive's (CPIL) net sales grew by 6.8% YoY to | 1091.1 crore (I-direct estimate: | 1056.8 crore) on the back of 6% volume...
|
|
25 May 2016
|
Colgate-Palmolive
|
Phillip Capital
|
2347.80
|
960.00
|
839.70
(179.60%)
|
Target met |
Buy
|
|
|
Revenue growth at 7% yoy percent was ahead of estimates. Organic revenue growth excluding phasing of excise duty benefits was a robust 13% yoy Volume growth at 6% yoy with Domestic volume growth of 4% yoy was ahead of...
|
|
24 May 2016
|
Colgate-Palmolive
|
Reliance Securities
|
2347.80
|
851.00
|
835.30
(181.07%)
|
Target met |
Accumulate
|
|
|
Colgate Palmolive (India) has reported mixed set of numbers for 4QFY16. While its revenues came in at Rs10.9bn (5% ahead of our estimate of Rs10.4bn), EBITDA and net profit came in 14% & 18% below our estimate at Rs2.3bn & Rs1.5bn respectively, which can be attributed to higher A&P; spends. The Company's net sales (excluding the impact of phasing-out of Excise Duties) grew by 13%, while net profit increased 14% in 4QFY16. We expect the Company to post revenue and earnings CAGR of 12.7% & 12%, respectively through FY16-18E and revise our recommendation on the stock from HOLD to ACCUMULATE with a Target Price of Rs851....
|
|
16 Mar 2016
|
Colgate-Palmolive
|
Phillip Capital
|
2347.80
|
1000.00
|
835.35
(181.06%)
|
Target met |
Buy
|
|
|
While Colgate continues to be the market leader in both toothbrushes and toothpastes by a considerable margin, its dominance has once again been challenged this time by Patanjali. Past contenders have included Anchor, Pepsodent, and Oral B. Patanjali's...
|
|
15 Mar 2016
|
Colgate-Palmolive
|
Phillip Capital
|
2347.80
|
1000.00
|
839.65
(179.62%)
|
Target met |
Buy
|
|
|
While Colgate continues to be the market leader in both toothbrushes and toothpastes by a considerable margin, its dominance has once again been challenged this time by Patanjali. Past contenders have included Anchor, Pepsodent, and Oral B. Patanjali's...
|
|
28 Jan 2016
|
Colgate-Palmolive
|
HDFC Securities
|
2347.80
|
905.00
|
850.20
(176.15%)
|
|
Hold
|
|
|
Colgates 3QFY16 revenues grew by a mere 1.9% YoY to Rs 10.1bn (vs. estimate of Rs 10.6bn). Impacted by the toothpaste category slowdown and rising competition, Colgate?s volume growth cracked to ~1%. Revenue growth was 7% excluding the impact of excise benefit withdrawal in Himachal Pradesh.
|
|
28 Jan 2016
|
Colgate-Palmolive
|
ICICI Securities Limited
|
2347.80
|
1018.00
|
850.20
(176.15%)
|
Target met |
Buy
|
|
|
|
|
28 Jan 2016
|
Colgate-Palmolive
|
Phillip Capital
|
2347.80
|
1000.00
|
850.20
(176.15%)
|
Target met |
Buy
|
|
|
Other expenses have seen blips quarter on quarter due to various reasons, the managementsees9monthstobemorereflectiveoffullyearFY16 WhileA&P;spendshavedeclinedforpasttwoquarters,managementcommentedthat...
|
|
27 Jan 2016
|
Colgate-Palmolive
|
Reliance Securities
|
2347.80
|
909.00
|
854.95
(174.61%)
|
|
Hold
|
|
|
Colgate reported net sales growth of just 1.8% to Rs10.1bn, which was lower than our estimates of Rs10.4bn. Volumes have grown by just 1% for the quarter. EBITDA came in at Rs2.2bn in line with our estimate, while reported net profit increased 21.8% to Rs1.6bn, higher than our estimate of Rs1.5bn. This out performance was attributable to tax reversal of Rs186mn in the quarter. We expect revenue and earnings CAGR of 9%...
|
|
02 Nov 2015
|
Colgate-Palmolive
|
Phillip Capital
|
2347.80
|
945.00
|
939.10
(150.01%)
|
|
Neutral
|
|
|
As exciseduty benefits have ceased, sales growth will be impacted by 580/600bps in Q3/Q4FY16andgrossmarginswillbeimpactedby150bps Employee spends in Q2FY15 (base quarter) had some exceptional items (expat debit...
|